Navigation Links
Array BioPharma Announces Exercise Of Underwriters' Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior Notes
Date:6/7/2013

BOULDER, Colo., June 7, 2013 /PRNewswire/ -- Array BioPharma Inc. (NasdaqGM: ARRY) announced today that the underwriters in its previously announced offering of 3.00% Convertible Senior Notes Due 2020 exercised in full their option to purchase an additional $17.25 million in aggregate principal amount of notes. Including the full exercise of the option, Array will issue a total of $132.25 million in aggregate principal amount of 3.00% Convertible Senior Notes Due 2020. Array anticipates that its aggregate net proceeds from the offering will be $128.0 million after deducting the underwriting discount and estimated offering expenses payable by Array, and expects to use approximately $92.6 million of the net proceeds to repay its outstanding secured indebtedness, with the remaining proceeds expected to be used for general corporate purposes. Goldman, Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, and Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as co-managers.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

The notes will be general senior unsecured obligations of Array. The notes will bear interest at a rate of 3.0% per year, payable semi-annually, and will mature on June 1, 2020. The notes will be convertible by the holders beginning March 1, 2020, or earlier upon specified events, and upon conversion, the holders will receive, at Array's option, shares of Array's common stock, cash or a combination of shares and cash. The notes will be convertible at an initial conversion rate of 141.8641 shares per $1,000 in principal amount of notes, equivalent to a conversion price of approximately $7.05 per share. Array may redeem some or all of the notes for cash under certain circumstances on or after June 4, 2
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... LONDON and BOSTON , January ... structure-guided drug discovery and development company, is delighted to announce ... has been awarded to Miles Congreve (Vice President ... co-founder) and Malcolm Weir (Chief Executive Officer and ...
(Date:1/22/2015)... RMD ) today announced results for its quarter ended ... a 10 percent increase compared to the quarter ended December ... basis). Net income was $91.2 million, an increase of 5 ... earnings per share for the quarter were $0.64, an increase ...
(Date:1/22/2015)... Increasing sophistication among enterprise buyers of language services ... 2015, says Moravia CMO, Renato Beninatto ... market research firm Common Sense Advisory, 15 percent of ... and localization needs. "From a language industry perspective, this ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... SAINT PAUL, Minn., March 5, 2012 Angeion Corporation (NASDAQ: ... Ph.D., has been appointed to the Company,s Board of Directors, ... currently Co-Director of the Center for Consumer Choice in Health ... position as Adjunct Associate Professor at the School of Nursing ...
... Physicians in AIDS Care (IAPAC) today announced the publication ... optimize entry into and retention in HIV care and ... into and Retention in Care and Antiretroviral Adherence for ... Panel and e-published today by the Annals of ...
Cached Medicine Technology:Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 2Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 3Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 4IAPAC Guidelines Offer Recommendations to Optimize Entry into and Retention in HIV Care, and Treatment Adherence 2IAPAC Guidelines Offer Recommendations to Optimize Entry into and Retention in HIV Care, and Treatment Adherence 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... , , WASHINGTON, July 9 The ... the work of the National Organization on Disability,s (N.O.D.) ... emergency managers and the disability community as the only ... and personnel experienced in emergency management and disability issues. ...
... 9 ICU Medical, Inc., (Nasdaq: ICUI ), ... products and critical care devices, announced today that it has ... rights and physical assets of Hospira, Inc.,s (NYSE: ... in cash. The acquisition is expected to close during the ...
... Inc. (Nasdaq: MAPP ) today announced that it ... with AstraZeneca related to the company,s Unit Dose Budesonide (UDB) ... 2009, effective immediately. All rights licensed to AstraZeneca in ... plans to suspend development of UDB, which did not meet ...
... , HOFFMAN ESTATES, Ill., July 9 Life Spine ... (FDA) has given 510(k) marketing clearance to the FS3 ... nationwide release this August, the FS3 MIS Spinal System ... instrumentation to accommodate a range of patient pathologies through ...
... SHENZHEN, China, July 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited ... and,marketer of medical devices worldwide, today announced that it ... June 30, 2009 after the U.S.,market closes on August ... at 8:00 AM on August 11, 2009 U.S. Eastern ...
... rebuke to the status quo in a deregulated trucking market, ... modernize transportation policy so the Port has the legal authority ... movement sustainable for local communities and workers. , , ... resolution at their July 21st board meeting immediately earned praise ...
Cached Medicine News:Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 2Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 3Health News:ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line 2Health News:ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line 3Health News:ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line 4Health News:ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line 5Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 2Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 3Health News:Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009 2Health News:Oakland Port Commission Seeks Resolution to Allow Local Officials Real Power to Clean Up Diesel Truck Pollution; Improve Security, Safety 2Health News:Oakland Port Commission Seeks Resolution to Allow Local Officials Real Power to Clean Up Diesel Truck Pollution; Improve Security, Safety 3Health News:Oakland Port Commission Seeks Resolution to Allow Local Officials Real Power to Clean Up Diesel Truck Pollution; Improve Security, Safety 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: